Cell rejuvenation atlas unveils master regulators of rejuvenation strategies

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science), Volume 16, Issue 17 on September 9, 2024, entitled, “The cell rejuvenation atlas: leveraging network biology to identify master regulators of rejuvenation strategies.”

BioLineRx’s Aphexda receives FDA approval for stem cell mobilisation

The treatment is intended for mobilising haematopoietic stem cells to peripheral blood. Credit: Terelyuk/Shutterstock.com. BioLineRx has received US Food and Drug Administration (FDA) approval for

September 12, 2023

PharmaDrug Inc. Completes Debt Restructuring | Psychedelic Invest

PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLD) (“PharmaDrug” or the “Company“), is pleased to announce that it has closed the previously announced debt restructuring (see

November 16, 2023

Opinion | ‘He Was Looking for Blood’: What We Heard This Week

“He was looking for blood.” — Theodore Pappas, MD, of Duke University in North Carolina, discussing how former President Theodore Roosevelt used his military training

July 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.